Categorias de Produtos
- Pó esteróide (51)
- líquido esteróide (73)
- SARM | peptídeos (50)
- outros produtos (47)
Ensaio: 98%+ por HPLC
quantidade mínima de encomenda(MOQ): 1 grama
forma de pagamento: Bitcoin, T / T, MoneyGram, Western Union
Tempo de espera: Dentro de 12 horas após o pagamento
Tempo de entrega: 3-7 dias de porta em porta
Embalagem: Super discreto
Remessa: DHL / TNT / UPS / HKEMS / FedEx / etc.
Numero de rastreio: Disponível após o pacote livrará.
Serviço pós-venda: 24/7 conectados
ACP-105 is another non-steroidal Selective Androgen Receptor Modulator (SARM).
Acadia proposes that ACP-105 is as potent as Testosterone in in vitro assays without interaction at other hormone receptors. além do que, além do mais, ACP-105 demonstrates potent anabolic effects on muscle and bone with minimal effect on prostrate in preclinical models (hence it being a genuine SARM).
While the research (albeit limited) is promising, there are no clinical studies on human subjects; consequently any conclusions or theories we develop around the compound have to be taken with a grain of salt.
Anything that suppresses your natural endocrine function warrants PCT in my opinion.
ACP-105 seems like it may be formidable to some of the less suppressive/still effective mainstream SARMs (like Ostarine) from the data we have gathered, but the main appeal of it is that there should be significantly less androgenic activity than several of the stronger SARMs, hence less undesirable side effects.
The studies done on ACP-105 suggest that the human equivalent for the study using 1 mg/kg per day for a man weighing about 175 pounds would be about 11 mg por dia.
Obviously equating this to some efficacious dosage where there would be minimal/no side effects for human use is impossible to do without some sort of experimentation being done, and as of now there are no clinical trials done on humans.
The consensus seems to suggest that a reasonable starting dosage is around 11-12mg per day for human research trials.